IL92735A - Nucleic acid molecules encoding a platelet- derived endothelial cell growth factor, process for the purification thereof and therapeutic compositions containing the same - Google Patents
Nucleic acid molecules encoding a platelet- derived endothelial cell growth factor, process for the purification thereof and therapeutic compositions containing the sameInfo
- Publication number
- IL92735A IL92735A IL92735A IL9273589A IL92735A IL 92735 A IL92735 A IL 92735A IL 92735 A IL92735 A IL 92735A IL 9273589 A IL9273589 A IL 9273589A IL 92735 A IL92735 A IL 92735A
- Authority
- IL
- Israel
- Prior art keywords
- subjecting
- purification
- pooling
- growth factor
- cell growth
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/22—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Biophysics (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Heart & Thoracic Surgery (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Cardiology (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Diabetes (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US28805688A | 1988-12-20 | 1988-12-20 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL92735A0 IL92735A0 (en) | 1990-09-17 |
| IL92735A true IL92735A (en) | 1998-06-15 |
Family
ID=23105561
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL92735A IL92735A (en) | 1988-12-20 | 1989-12-15 | Nucleic acid molecules encoding a platelet- derived endothelial cell growth factor, process for the purification thereof and therapeutic compositions containing the same |
Country Status (13)
| Country | Link |
|---|---|
| EP (2) | EP0685490A1 (da) |
| JP (1) | JPH02288897A (da) |
| KR (1) | KR900009989A (da) |
| AT (1) | ATE145242T1 (da) |
| AU (1) | AU4687989A (da) |
| CA (1) | CA2005600A1 (da) |
| DE (1) | DE68927458T2 (da) |
| DK (1) | DK643389A (da) |
| FI (1) | FI896137A7 (da) |
| IL (1) | IL92735A (da) |
| NO (1) | NO895055L (da) |
| NZ (1) | NZ231837A (da) |
| PT (1) | PT92613B (da) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI890342L (fi) * | 1988-01-25 | 1989-07-26 | American Cyanamid Co | Hjaernmitogener, som binds till heparin. |
| CA2005600A1 (en) | 1988-12-20 | 1990-06-20 | Cal-Henrik Heldin | Endothelial cell growth factor |
| ES2123004T3 (es) * | 1991-04-12 | 1999-01-01 | Creative Biomolecules Inc | Uso de factor de crecimiento derivado de plaquetas en la preparacion de un medicamento para el tratamiento de ulceras gastrointestinales. |
| DE4118912C1 (da) * | 1991-06-08 | 1992-07-02 | Biotest Pharma Gmbh, 6072 Dreieich, De | |
| GB9121815D0 (en) * | 1991-10-15 | 1991-11-27 | Delta Biotechnology Ltd | Medicine |
| EP0697883A1 (en) * | 1993-04-29 | 1996-02-28 | Washington University | Use of platelet-derived growth factor to improve collateral circulation |
| JP3268147B2 (ja) * | 1994-12-28 | 2002-03-25 | 大鵬薬品工業株式会社 | モノクローナル抗体 |
| AU729459B2 (en) * | 1996-11-15 | 2001-02-01 | Genentech Inc. | Purification of neurotrophins |
| AT407484B (de) * | 1997-11-12 | 2001-03-26 | Bio Prod & Bio Eng Ag | Arzneimittel zur förderung der wundheilung |
| AUPP263498A0 (en) * | 1998-03-27 | 1998-04-23 | Walter And Eliza Hall Institute Of Medical Research, The | Novel therapeutic molecules and uses therefor |
| ES2402144T3 (es) * | 2010-05-25 | 2013-04-29 | Gwowei Technology Co., Ltd. | Lisado plaquetario inactivado que contiene factores de crecimiento empobrecido en PDGF y VEGF y su procedimiento de preparación |
| WO2012102100A1 (ja) | 2011-01-26 | 2012-08-02 | 雪印メグミルク株式会社 | 感覚改善剤 |
| HK1221402A1 (zh) | 2013-04-02 | 2017-06-02 | University Of Florida Research Foundation, Inc. | 用於诱导并调节血管生成的组合物和方法以及用於鉴别血管生成调节剂的方法和实验 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2005600A1 (en) | 1988-12-20 | 1990-06-20 | Cal-Henrik Heldin | Endothelial cell growth factor |
-
1989
- 1989-12-14 CA CA002005600A patent/CA2005600A1/en not_active Abandoned
- 1989-12-15 AT AT89123229T patent/ATE145242T1/de not_active IP Right Cessation
- 1989-12-15 DE DE68927458T patent/DE68927458T2/de not_active Expired - Fee Related
- 1989-12-15 EP EP95108643A patent/EP0685490A1/en not_active Withdrawn
- 1989-12-15 IL IL92735A patent/IL92735A/xx not_active IP Right Cessation
- 1989-12-15 NO NO89895055A patent/NO895055L/no unknown
- 1989-12-15 EP EP89123229A patent/EP0377855B1/en not_active Expired - Lifetime
- 1989-12-18 DK DK643389A patent/DK643389A/da not_active Application Discontinuation
- 1989-12-18 AU AU46879/89A patent/AU4687989A/en not_active Abandoned
- 1989-12-18 NZ NZ231837A patent/NZ231837A/en unknown
- 1989-12-19 PT PT92613A patent/PT92613B/pt not_active IP Right Cessation
- 1989-12-20 JP JP1328567A patent/JPH02288897A/ja active Pending
- 1989-12-20 KR KR1019890019355A patent/KR900009989A/ko not_active Ceased
- 1989-12-20 FI FI896137A patent/FI896137A7/fi not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| DK643389A (da) | 1990-06-21 |
| DE68927458D1 (de) | 1996-12-19 |
| JPH02288897A (ja) | 1990-11-28 |
| PT92613B (pt) | 1996-09-30 |
| DK643389D0 (da) | 1989-12-18 |
| FI896137A7 (fi) | 1990-06-21 |
| EP0377855A2 (en) | 1990-07-18 |
| EP0685490A1 (en) | 1995-12-06 |
| EP0377855A3 (en) | 1990-12-19 |
| DE68927458T2 (de) | 1997-04-03 |
| CA2005600A1 (en) | 1990-06-20 |
| PT92613A (pt) | 1990-06-29 |
| KR900009989A (ko) | 1990-07-06 |
| NO895055D0 (no) | 1989-12-15 |
| IL92735A0 (en) | 1990-09-17 |
| EP0377855B1 (en) | 1996-11-13 |
| FI896137A0 (fi) | 1989-12-20 |
| AU4687989A (en) | 1990-06-28 |
| ATE145242T1 (de) | 1996-11-15 |
| NZ231837A (en) | 1992-03-26 |
| NO895055L (no) | 1990-06-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL92735A (en) | Nucleic acid molecules encoding a platelet- derived endothelial cell growth factor, process for the purification thereof and therapeutic compositions containing the same | |
| FI922824L (fi) | Renat immunoglobulin. | |
| NO945032L (no) | Fremgangsmåte for fremstilling av et konsentrat av Anti-D-Immunglobulin D samt farmasöytisk preparat inneholdende dette | |
| AU645094B2 (en) | Method of treating bladder cancer cells | |
| KR890701618A (ko) | 단백질 정제방법 | |
| DE2924744C2 (de) | Gewinnung von reiner Urokinase | |
| EP0212688A3 (en) | Substituted and crosslinked glucans, process for preparing them and use thereof | |
| ES2093031T3 (es) | Metodo para purificar el factor de crecimiento transformante (tgf). | |
| CA2023405A1 (en) | Process for purifying n-phosphonomethylglycine | |
| EP0289129A3 (en) | High purity protein a preparation | |
| SE7909897L (sv) | Rening av gammaglobulinderivat | |
| DE3788170D1 (de) | Methode zur Reinigung und Isolierung von zwei ionischen Formen von Somatomedin. | |
| GR3004622T3 (da) | ||
| ES8304450A1 (es) | Un metodo para regenerar una resina de intercambio cationico. | |
| FR2616782B1 (fr) | Procede de separation d'acides amines | |
| Buday et al. | Production of demineralized water and ammonium nitrate solution from effluents in ammonia production | |
| JPS54138189A (en) | Separation and purification of urokinase | |
| TW260624B (en) | Process of separating tryptophan (Trp) from zymotic fluid by ion-exchange displacement chromatography | |
| RO103684A2 (en) | PRODUCTION METHOD OF IMMUNO-GLOBULIN A1(IgA1) | |
| FR2423987A1 (fr) | Procede de preparation d'une substance proteinique a partir d'une levure, substance obtenue selon ce procede et son application dans le domaine de la nutrition | |
| RU93037415A (ru) | Способ промышленного получения (6s)-изомеров методом хроматографического разделения | |
| DD215319A1 (de) | Verfahren zur anreicherung von interferonen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| MM9K | Patent not in force due to non-payment of renewal fees |